News
Teladoc stock gains as Citron Research posts a bullish report in its favor. Wall Street remains positive on TDOC shares for ...
I maintain my Buy rating on Teladoc Health due to positive acquisitions and a robust balance sheet, despite recent weak Q1 ...
Teladoc Health (TDOC) stock rallies as Citron Research issues a bullish report on the company. Read more here.
Shares of digital medical services platform Teladoc Health (NYSE:TDOC) jumped 10.9% in the afternoon session after Citron Research published a report highlighting the company's growth potential ...
Teladoc Health Inc (NYSE:TDOC) shares are rising Monday after Citron Research made positive comments about the company on its ...
Citron Research described Teladoc as a "coiled spring," noting that despite being the world’s largest telehealth platform with a market capitalization of just $1.2 billion, it owns BetterHelp, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results